Literature DB >> 9916726

Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma.

C A Rumbley1, H Sugaya, S A Zekavat, M El Refaei, P J Perrin, S M Phillips.   

Abstract

Eosinophils are a numerically dominant cell population within the schistosome granuloma. These granuloma eosinophils can produce a variety of cytokines, including IL-2, IL-4, IL-5, and IFN-gamma. Therefore, eosinophils may play a key role in the determination of the unique cytokine microenvironment within the granuloma milieu. These studies investigated the potential role of eosinophils in the regulation of granuloma immunopathology. We have characterized spleen- and granuloma-derived eosinophils based on cellular activation and cytokine production during the development of murine schistosomiasis. Based on the criteria of hypodensity and CD69 expression, granuloma eosinophils were highly activated and very homogeneous at 7 and 11 wk postinfection. Splenic eosinophils were also activated at 7 wk postinfection, but were much more heterogeneous than their granuloma counterparts. By 11 wk postinfection, few hypodense splenic eosinophils were observed. Eosinophils represented the majority of cytokine-producing cells in the granuloma and were a dominant source of IL-4. Eosinophils also produced IL-2, IL-5, and IFN-gamma, using the criteria of mRNA in situ hybridization and intracellular cytokine staining by FACS. Granuloma eosinophil activation and cytokine production were greatest at the time of maximum granuloma formation, i.e., 10-12 wk after initial cercarial exposure. Therefore, locally activated eosinophils, not Th2 lymphocytes, produce the majority of Th2 cytokines in the granuloma milieu and may be important determinators of immunopathology in schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916726

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Regulation of granulomatous inflammation in experimental models of schistosomiasis.

Authors:  Abram B Stavitsky
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

Review 3.  Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation.

Authors:  Zhou Zhu; Sun Young Oh; You Sook Cho; Li Zhang; Yoon-Keun Kim; Tao Zheng
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

4.  Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma.

Authors:  E L van Rensen; R G Stirling; J Scheerens; K Staples; P J Sterk; P J Barnes; K F Chung
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

5.  Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice.

Authors:  M P Macias; L A Fitzpatrick; I Brenneise; M P McGarry; J J Lee; N A Lee
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 6.  Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space.

Authors:  Anupama Ariyaratne; Constance A M Finney
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

7.  Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection.

Authors:  Jessica C Jang; Meera G Nair
Journal:  Curr Immunol Rev       Date:  2013-08-01

8.  TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis.

Authors:  Mosiuoa Leeto; De'Broski R Herbert; Reece Marillier; Anita Schwegmann; Lizette Fick; Frank Brombacher
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

10.  Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.

Authors:  Rachael M Reiman; Robert W Thompson; Carl G Feng; Danielle Hari; Rachel Knight; Allen W Cheever; Helene F Rosenberg; Thomas A Wynn
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.